CHRS · Insider trading · 13F holders · Congress trades
Coherus BioSciences, Inc. (CHRS)
Who is buying and selling CHRS: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 4
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 1
CHRS at a glance
- No open-market insider purchases or sales of CHRS were filed in the last 90 days.
- 4 13F filers hold CHRS among their 50 largest positions, worth $27.7M combined. The biggest bets by portfolio weight are Timothy G. Youngquist 2020 Irrevocable Trust (3.1%), CM Management, LLC (1.9%) and Samsara Biocapital, LLC (0.4%).
- Members of Congress have disclosed 1 CHRS trade since 2023, 0 purchases and 1 sale in the past year; the latest was Shri Thanedar (D-MI), selling $15K–50K on Jan 23, 2023.
- CHRS last closed at $0.86 on Oct 30, 2026.
CHRS insider trading
No open-market insider purchases or sales of CHRS were filed in the last 90 days.
Who owns CHRS? Hedge funds and superinvestors
4 13F filers hold CHRS among their 50 largest positions, worth $27.7M combined. The biggest bets by portfolio weight are Timothy G. Youngquist 2020 Irrevocable Trust (3.1%), CM Management, LLC (1.9%) and Samsara Biocapital, LLC (0.4%).
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable TrustInvestment manager | 3.1% | $15.8M | 13,050,623 | +0.0% shares | Q3 2026 |
| Samsara Biocapital, LLCHedge fund | 0.4% | $4.8M | 3,428,571 | +0.0% shares | Q2 2026 |
| Kohlberg Kravis Roberts & Co. L.P.Hedge fund | 0.1% | $4.2M | 3,036,076 | +0.0% shares | Q2 2026 |
| CM Management, LLCHedge fund | 1.9% | $2.9M | 2,100,000 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 3). Screen CHRS in the grand portfolio →
CHRS stock trades by members of Congress
Members of Congress have disclosed 1 CHRS trade since 2023, 0 purchases and 1 sale in the past year; the latest was Shri Thanedar (D-MI), selling $15K–50K on Jan 23, 2023.
| Filed | Member | Trade | Amount | Traded | Since |
|---|---|---|---|---|---|
| Feb 9, 2023 | Shri ThanedarD-MI · House | Sale | $15K–50K | Jan 23, 2023 | -90.7% |
CHRS questions and answers
Are insiders buying CHRS stock?
No open-market insider purchases or sales of CHRS were filed in the last 90 days.
Which hedge funds own CHRS?
4 13F filers hold CHRS among their 50 largest positions, worth $27.7M combined. The biggest bets by portfolio weight are Timothy G. Youngquist 2020 Irrevocable Trust (3.1%), CM Management, LLC (1.9%) and Samsara Biocapital, LLC (0.4%).
Has Congress traded CHRS?
Members of Congress have disclosed 1 CHRS trade since 2023, 0 purchases and 1 sale in the past year; the latest was Shri Thanedar (D-MI), selling $15K–50K on Jan 23, 2023.
Who is the largest holder of CHRS?
Among 13F filers, Timothy G. Youngquist 2020 Irrevocable Trust reports the largest CHRS position, $15.8M (13,050,623 shares) in its Q3 2026 13F. The biggest bet by portfolio weight is Timothy G. Youngquist 2020 Irrevocable Trust's: 3.1% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.